What is 10x Genomics, Inc.'s change in accrued liabilities?

10x Genomics, Inc. (TXG) reported change in accrued liabilities of -$613K in Q1 2026.

What is the long-term trend for 10x Genomics, Inc.'s change in accrued liabilities?

Over 2 years (2021 to 2025), 10x Genomics, Inc.'s change in accrued liabilities has grown at a -31.6% compound annual growth rate (CAGR), from $16.34M to $7.65M.

What does change in accrued liabilities mean?

Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.

10x Genomics, Inc. TXG Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

TEC

Bio-TechneTECH

-$22.1M-168%

BrukerBRKR

-$6.68M-273%

IlluminaILMN

-$47M+16.1%

Twist Bioscience CorporationTWST

-$5.78M-4,256%

RevvityRVTY

-$74.69M-115%

Tempus AI, Inc.TEM

$5.26M+119%

Other financials

Income statement

See full

Revenue$150.8M-2.6%

Gross profit$106.2M+0.7%

Operating income-$17.0M+56.7%

Net income-$13.5M+60.8%

EPS (diluted)-$0.10+64.3%

Balance sheet

See full

Cash & equivalents$490.3M+30.0%

Total debt$81.4M+1.6%

Total equity$814.3M+15.2%

Total assets$1.0B+12.4%

Cash flow

See full

Operating cash flow$26.1M-24.0%

CapEx$1.6M-15.6%

Free cash flow$24.5M-24.4%

Valuation

See full

Market cap$4.41B+154%

Enterprise value$4B+199%

P/S6.9×+4.1×

Profitability

See full

Gross margin69.6%+1.2pp

Operating margin-6.1%-2.7pp

Net margin-3.5%-1.6pp

FCF margin19.1%—

Returns & leverage

See full

Return on equity-3%-1.4pp

Debt / equity0.1×0.0×

Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 10x Genomics, Inc.'s change in accrued liabilities?: 10x Genomics, Inc. (TXG) reported change in accrued liabilities of -$613K in Q1 2026.
What is the long-term trend for 10x Genomics, Inc.'s change in accrued liabilities?: Over 2 years (2021 to 2025), 10x Genomics, Inc.'s change in accrued liabilities has grown at a -31.6% compound annual growth rate (CAGR), from $16.34M to $7.65M.
What does change in accrued liabilities mean?: Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.